Climb Bio Inc
Healthcare · Biotechnology
CLARITY GRADE · crash risk, updated Tuesdays
week of Nov 16
FRACTURED
6 weeks at this grade
More of these stocks dropped 20%+ than rose 20%+.
| Fact | This stock | Similar stocks that dropped 20%+ |
|---|---|---|
| Price swings, last 60 days | wilder than 81% of stocks under $10B | 44 vs typical 23 of 100 |
| Distance below its 52-week high | 44% below | 26 vs typical 23 of 100 |
| Finances vs industry peers (return on equity, operating cash flow) | return on equity above 70% of peers, cash flow yield above 59% | 15 vs typical 23 of 100 |
| New shares issued over the last year | share count -13.9% | 19 vs typical 23 of 100 |
| Trading heat vs peers (shares traded / shares outstanding) | more than 76% of peers |
| 20 vs typical 23 of 100 |
Past stocks scored each week from January 2024 to June 2026, using only data available at the time, then checked 60 trading days later. A grade is about holding up, not about gains, and it is not a buy or sell signal. How the grades are tested